Business
TRxADE HEALTH Announces Termination of Public Offering of Common Stock
LUTZ, FL / ACCESSWIRE / August 24, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing
About this update from Scienture Holdings, Inc.
[{"type":"text","content":"LUTZ, FL / ACCESSWIRE / August 24, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) (\"TRxADE\" or the \"Company\"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it has terminated the proposed underwritten public offering previously announced on August 23, 2022. The termination results from an assessment by the Company's management that current market conditions are not conducive for an offering on terms that would be in the best interests of the Company's stockholders. As a result of such termination, no shares of common stock will be sold pursuant to the offering.The offering was being made pursuant to a \"shelf\" registration statement on Form S-3 (File No. 333- 266432) filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on August 8, 2022, and the accompanying prospectus contained therein. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About TRxADE HEALTH, Inc.TRxADE HEALTH, Inc. (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 13,815+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services and tele vet services. For more information on TRxADE Health, please visit the Company's IR website at investors.trxadehealth.com.Forward-Looking StatementsThis press release may contain forward-looking statements, including information about management's view of TRxADE's future expectations, plans and prospects, within the meaning of the federal securities laws, including the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words \"may,\" \"could,\" \"expect,\...